BOK Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-167,735
Closed -$13.2M 1445
2024
Q2
$13.2M Sell
167,735
-18,403
-10% -$1.51M 0.24% 85
2024
Q1
$16.2M Sell
186,138
-1,070
-0.6% -$91.3K 0.29% 71
2023
Q4
$15.4M Sell
187,208
-14,341
-7% -$1.09M 0.3% 74
2023
Q3
$14.2M Sell
201,549
-6,900
-3% -$578K 0.31% 71
2023
Q2
$18.4M Buy
208,449
+17,033
+9% +$1.47M 0.37% 58
2023
Q1
$15.4M Buy
191,416
+115,779
+153% +$9.44M 0.32% 76
2022
Q4
$5.88M Sell
75,637
-10,933
-13% -$886K 0.11% 181
2022
Q3
$6.99M Sell
86,570
-154,927
-64% -$13.9M 0.14% 153
2022
Q2
$21.7M Buy
241,497
+40,690
+20% +$4.12M 0.42% 59
2022
Q1
$22.3M Buy
200,807
+23,352
+13% +$2.47M 0.37% 64
2021
Q4
$18.4M Sell
177,455
-10,590
-6% -$1.23M 0.28% 83
2021
Q3
$23.6M Buy
+188,045
New +$24.3M 0.41% 58
2021
Q1
$9.83M Sell
83,227
-3,992
-5% -$468K 0.18% 123
2020
Q4
$10.2M Sell
87,219
-27,513
-24% -$3.03M 0.19% 117
2020
Q3
$11.9M Buy
114,732
+22,185
+24% +$2.23M 0.26% 89
2020
Q2
$8.49M Buy
92,547
+5,977
+7% +$573K 0.2% 116
2020
Q1
$7.81M Buy
86,570
+27,353
+46% +$2.91M 0.22% 102
2019
Q4
$6.72M Buy
59,217
+1,069
+2% +$117K 0.15% 154
2019
Q3
$6.32M Sell
58,148
-457
-0.8% -$47.7K 0.15% 156
2019
Q2
$5.71M Sell
58,605
-940
-2% -$85.8K 0.14% 175
2019
Q1
$5.42M Sell
59,545
-1,187
-2% -$106K 0.13% 178
2018
Q4
$5.52M Sell
60,732
-3,547
-6% -$331K 0.16% 144
2018
Q3
$6.32M Sell
64,279
-676
-1% -$62.5K 0.16% 164
2018
Q2
$5.56M Sell
64,955
-2,734
-4% -$228K 0.15% 164
2018
Q1
$5.43M Buy
67,689
+12,256
+22% +$1.01M 0.15% 158
2017
Q4
$4.48M Sell
55,433
-54,630
-50% -$4.38M 0.12% 188
2017
Q3
$8.56M Buy
110,063
+11,614
+12% +$964K 0.25% 93
2017
Q2
$8.74M Sell
98,449
-1,464
-1% -$123K 0.27% 87
2017
Q1
$8.05M Sell
99,913
-2,982
-3% -$233K 0.25% 94
2016
Q4
$7.33M Buy
102,895
+1,048
+1% +$82.3K 0.24% 94
2016
Q3
$8.8M Buy
101,847
+15,663
+18% +$1.36M 0.29% 84
2016
Q2
$7.48M Buy
86,184
+889
+1% +$71.9K 0.26% 93
2016
Q1
$6.4M Sell
85,295
-5,534
-6% -$417K 0.23% 101
2015
Q4
$6.99M Sell
90,829
-343
-0.4% -$25.8K 0.25% 91
2015
Q3
$6.1M Sell
91,172
-12,171
-12% -$896K 0.23% 100
2015
Q2
$7.66M Buy
103,343
+14,312
+16% +$1.09M 0.26% 91
2015
Q1
$6.94M Buy
89,031
+19,748
+29% +$1.5M 0.23% 101
2014
Q4
$5M Sell
69,283
-19,695
-22% -$1.37M 0.17% 138
2014
Q3
$5.51M Sell
88,978
-716
-0.8% -$45.5K 0.18% 122
2014
Q2
$5.72M Sell
89,694
-48,908
-35% -$2.97M 0.18% 127
2014
Q1
$8.53M Sell
138,602
-4,366
-3% -$254K 0.28% 79
2013
Q4
$8.21M Buy
142,968
+4,711
+3% +$267K 0.27% 82
2013
Q3
$7.36M Sell
138,257
-1,405
-1% -$75.6K 0.27% 87
2013
Q2
$7.19M Buy
+139,662
New +$6.9M 0.27% 86

Other funds holding MDT

BOK Financial's MDT Position: Q3 2024 in Review

BOK Financial sold out of Medtronic (MDT) in Q3 2024, closing a stake of 167,735 shares — an estimated $13.2M sold.

BOK Financial first reported a position in MDT in Q2 2013 and held it in 44 quarters. The position peaked at $23.6M in Q3 2021. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • BOK Financial reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • BOK Financial sold 167,735 Medtronic shares in Q3 2024, an estimated $13.2M.
  • BOK Financial first reported a position in Medtronic in Q2 2013 and held it in 44 quarters.
  • BOK Financial's Medtronic position peaked at $23.6M in Q3 2021.
  • 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on BOK Financial's 13F filing for Q3 2024, filed 14 Nov 2024.